Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally

Immunity

Volumn 9, Issue 2, 1998, Pages 267-276

  Varfolomeev, Eugene E ^a   Schuchmann, Marcus ^a   Luria, Victor ^a   Chiannilkulchai, Nuchanard ^b,f   Beckmann, Jacques S ^b   Mett, Igor L ^a   Rebrikov, Denis ^a   Brodianski, Vadim M ^a   Kemper, Oliver C ^a   Kollet, Orit ^a   Lapidot, Tsvee ^a   Soffer, Dror ^c   Sobe, Tama ^d   Avraham, Karen B ^d   Goncharov, Tanya ^a   Holtmann, Helmut ^e   Lonai, Peter ^a   Wallach, David ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b GÉNÉTHON   (France)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f CENTRE NATIONAL DE SÉQUENÇAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DEATH; EMBRYO; EMBRYO DEVELOPMENT; FIBROBLAST; GENE DISRUPTION; GENE MAPPING; HOMOZYGOSITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

EID: 0032143986     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80609-3     Document Type: Article

References (59)

1. Ahmad, M., Srinivasula, S.M., Wang, L., Talanian, R.V., Litwack, G., Fernandes-Alnemri, T., and Alnemri, E.S. (1997). CRADD, a novel human apoptotic adaptor molecule forcaspase-2, and FasL/tumor necrosis factor-interacting protein RIP. Cancer Res. 57, 615-619.
2. Almazan, G., and McKay, R. (1992). An oligodendrocyte precursor cell line from rat optic nerve. Brain Res. 579, 234-245.
3. Bodmer, J.-L., Burns, K., Schneider, P., Hofmann, K., Steiner, V., Thome, M., Bornand, T., Hahne, M., Schröter, M., Becker, K., et al. (1997). TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6, 79-88.
4. Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO1-and TNF receptor-induced cell death. Cell 85, 803-815.
5. Bossy-Wetzel, E., Newmeyer, D.D., and Green, D.R. (1998). Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17, 37-49.
6. Chaudhary, P.M., Eby, M., Jasmin, A., Bookwalter, A., Murray, J., and Hood, L. (1997). Death receptors, a new member of the TNFR family, and DR4 induce FADD dependent apoptosis and activate the NF κB pathway. Immunity 7, 821-830.
7. Chen, Y.R., Wang, X., Templeton, D., Davis, R.J., and Tan, T.H. (1996). The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271, 31929-31936.
8. Chinnaiyan, A.M., O'Rourke, K., Yu, G.L., Lyons, R.H., Garg, M., Duan, D.R., Xing, L., Gentz, R., Ni, J., and Dixit, V.M. (1996). Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990-992.
9. Conlon, R.A., and Herrmann, B.G. (1992). Detection of messenger RNA by in situ hybridization to post implantation embryo whole mounts. Methods Enzymol. 225, 361-372.
10. Duan, H., and Dixit, V.M. (1997). RAIDD is a new "death" adapter molecule. Nature 385, 86-89.
11. Engelmann, H., Holtmann, H., Brakebusch, C., Shemer Avni, Y., Sarov, I., Nophar, Y., Hadas, E., Leitner, O., and Wallach, D. (1990). Antibodies to a soluble form of a tumor necrosis factor receptor have TNF-like activity. J. Biol. Chem. 265, 14497-14504.
12. Fernandes-Alnemri, T., Armstrong, R.C., Krebs, J., Srinivasula, S.M., Wang, L., Bullrich, F., Fritz, L.C., Trapani, J.A., Tomaselli, K.J., Litwack, G., and Alnemri, E.S. (1996). In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containig two FADD-like domains. Proc. Natl. Acad. Sci. USA 93, 7464-7469.
13. Finter, N.B. (1969). Dye uptake methods for assessing viral cytopathogenicity and their application to Interferon assays. J. Gen. Virol. 5,419-427.
14. Goillot, E., Raingeaud, J., Ranger, A., Tepper, R.I., Davis, R.J., Harlow, E., and Sanchez, I. (1997). Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc. Natl. Acad. Sci. USA 94, 3302-3307.
15. Gruss, H.J., and Dower, S.K. (1995). The TNF ligand superfamily and its relevance for human diseases. Cytokines Mol. Ther. 1, 75-105.
16. Han, D., Chaudhary, P., Wright, M., Friedman, C., Trask, B., Riedel, R., Baskin, D., Schwartz, S., and Hood, L. (1997). MRIT, a novel death-effector domain-containing protein, interacts with caspases and BcIXI and initiates cell death. Proc. Natl. Acad. Sci. USA 94, 11333-11338.
17. Jacobsen, M.D., Weil, M., and Raff, M.C. (1996). Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J. Cell. Biol. 133, 1041-1051.
18. Kelliher, M.A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B.Z., and Leder, P. (1998). The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8, 297-303.
19. Kerkhoff, E., and Rapp, U.R. (1997). Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. Mol. Cell. Biol. 17, 2576-2586.
20. Kitson, J., Raven, T., Jiang, Y.-P., Goeddel, D.V., Giles, K.M., Pun, K.-T., Grinham, C.J., Brown, R., and Farrow, S.N. (1996). A death-domain-containing receptor that mediates apoptosis. Nature 384, 372-375.
21. Kyriakis, J.M., and Avruch, J. (1996). Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18, 567-577.
22. Lallemand, Y., Luria, V., Haffner-Krausz, R., and Lonai, P. (1998). Maternally expressed PGK-Cre trangene as a tool for early and uniform activation of the Cre site-specific recombinase. Transgenic Res. 7, 105-112.
23. Latinis, K.M., and Koretzky, G.A. (1996). Fas ligationinduces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood 87, 871-875.
24. Lenczowski, J.M., Dominguez, L., Eder, A.M., King, L.B., Zacharchuk, C.M., and Ashwell, J.D. (1997). Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol. Cell. Biol. 17, 170-181.
25. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S., and Wang, X. (1997). Cytochromec and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
26. Manly, K.F. (1993). A Macintosh program for storage and analysis of experimental genetic mapping data. Mamm. Genome 4, 303-313.
27. Mansour, S.L., Thomas, K.R., and Capecchi, M.R. (1988). Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336, 348-352.
28. Marsters, S.A., Sheridan, J.P., Donahue, C.J., Pitti, R.M., Gray, C.L., Goddard, A.D., Bauer, K.D., and Ashkenazi, A. (1996a). Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB. Curr. Biol. 6, 1669-1676.
29. Marsters, S.A., Pitti, R.M., Donahue, C.J., Ruppert, S., Bauer, K.D., and Ashkenazi, A. (1996b). Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr. Biol. 6, 750-752.
30. Marsters, S.A., Sheridan, J.P., Pitti, R.M., Brush, J., Goddard, A., and Ashkenazi, A. (1998). Identification of a ligand for the death-domain-containing receptor Apo3. Curr. Biol. 8, 525-528.
31. Martins, L.M., Kottke, T., Mesner, P.W., Basi, G.S., Sinha, S., Frigon, N., Jr., Tatar, E., Tung, J.S., Bryant, K., Takahashi, A., et al. (1997). Activation of multiple interleukin-1 β converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J. Biol. Chem. 272, 7421-7430.
32. Matsumoto, M., Fu, Y.X., Molina, H., and Chaplin, D.D. (1997). Lymphotoxin-α-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers, Immunol. Rev. 156, 137-144.
33. Meyer, D., and Birchmeier, C. (1995). Multiple essential functions of neuregulin in development. Nature 378, 386-390.
34. Morgenstern, J.P., and Land, H. (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596.
35. Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., et al. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827.
36. Nagata, S., and Golstein, P. (1995). The Fas death factor. Science 267, 1449-1456.
37. Nagy, A., and Rossant, J. (1993). Production of completely ES cell derived fetuses. In Gene Targeting: A Practical Approach, A.L. Joyner, ed. (Oxford: Oxford U. Press), pp. 147-179.
38. Nicholson, D.W., and Thornberry, N.A. (1997). Caspases: killer proteases. Trends Biochem. Sci. 22, 299-306.
39. Orr-Urtreger, A., Bedford, M.T., Burakova, T., Arman, E., Zimmer, Y., Yayon, A., Givol, D., and Lonai, P. (1993). Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Developmental Biology 158, 475-486.
40. Pan, G., O'Rourke, K., Chinnaiyan, A.M., Gentz, R., Ebner, R., Ni, J., and Dixit, V.M. (1997). The receptor for the cytotoxic ligand TRAIL. Science 276, 111-113.
41. Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396.
42. Rasper, D.M., Vaillancourt, J.P., Hadano, S., Houtzager, V.M., Seiden, I., Keen, S.L. C., Tawa, P., Xanthoudakis, S., Nasir, J., Martindale, D., et al. (1998). Cell death attenuation by "Usurpin", a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ. 5, 271-288.
43. Roulston, A., Reinhard, C., Amiri, P., and Williams, L.T. (1998). Early activation of c-Jun n-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor α. J. Biol. Chem. 273, 10232-10239.
44. Rowe, L.B., Nadeau, J.H., Turner, R., Frankel, W.N., Letts, V.A., Eppig, J.T., Ko, M.S., Thurston, S.J., and Birkenmeier, E.H. (1994). Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. Mamm. Genome 5, 253-274.
45. Schneider, P., Thome, M., Burns, K., Bodmer, J.L., Hofmann, K., Kataoka, T., Holler, N., and Tschopp, J. (1997). TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 7, 831-836.
46. Stancovski, I., and Baltimore, D. (1997). NF-κB Activation: the lκB kinase revealed? Cell 91, 299-302.
47. Ting, AT., Pimentel Muinos, F.X., and Seed, B. (1996). RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/ APO-1-initiated apoptosis. EMBO J. 15, 6189-6196.
48. Todaro, G.J., and Green, H. (1963). Quantitative studies of the growth of mouse embryo cells in culture and theirdevelopmewnt into established lines. J. Cell Biol. 17, 299-313.
49. Villa, P., Kauf man, S.H., and Earnshaw, W.C. (1997). Caspases and caspase inhibitors. Trends Biochem. Sci. 22, 388-393.
50. Vincenz, C., and Dixit, V.M. (1997). Fas-associated death domain protein interleukin-1 b-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, isproximally involved in CD95-and p55-mediated death signaling. J. Biol. Chem. 272, 6578-6583.
51. Wajant, H., Johannes, F.J., Haas, E., Siemienski, K., Schwenzer, R., Schubert, G., Weiss, T., Grell, M., and Scheurich, P. (1998). Dominant-negative FADD inhibits TNFR60-, Fas/Apo1-and TRAIL-R/ Apo2-mediated cell death but not gene induction. Curr. Biol. 8, 113-116.
52. Walczak, H., Degli-Esposti, M.A., Johnson, R.S., Smolak, P.J., Waugh, J. Y., Boiani, N., Timour, M.S., Gerhart, M.J., Schooley, K.A., Smith, C.A., et al. (1997). TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16, 5386-5397.
53. Wallach, D. (1984). Preparations of lymphotoxin induce resistance to their own cytotoxic effect. J. Immunol. 132, 2464-2469.
54. Wallach, D. (1997). Apoptosis. Placing death under control. Nature 388, 125-126.
55. Watanabe, F.R., Brannan, C.I., ltoh, N., Yonehara, S., Copeland, N.G., Jenkins, N.A., and Nagata, S. (1992). The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274-1279.
56. Yang, X., Khosravi Far, R., Chang, H.Y., and Baltimore, D. (1997). Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89, 1067-1076.
57. Yeh, W., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J., Ferrick, D., Hum, B., Iscove, N., et al. (1997). Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715-725.
58. Yeh, W.C., Pompa, J.L, McCurrach, M.E., Shu, H.B., Elia, A.J., Shahinian, A., Ng, M., Wakeham, A., Khoo, W., Mitchell, K., et al. (1998). FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954-1958.
59. Zhang, J., Cado, D., Chen, A., Kabra, N.H., and Winoto, A. (1998). Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392, 296-300.